Dr.Zone AI

Dr.Yahya AlThamary | Cardiology | Dr.Zone AI

Dr.Yahya AlThamary (Cardiology): For symptomatic PAD, management has evolved beyond single antiplatelet therapy. The COMPASS regimen (Rivaroxaban 2.5 mg BID + Aspirin) is now advised